Literature DB >> 1783405

Genetic and physical mapping around the properdin P gene.

M P Coleman1, J C Murray, H F Willard, K F Nolan, K B Reid, D J Blake, S Lindsay, S S Bhattacharya, A Wright, K E Davies.   

Abstract

A CA repeat has been found on the human X chromosome within 16 kb of the gene encoding properdin P factor (PFC) and has been shown to be a highly informative marker. Two more polymorphic CA repeats were found in a cosmid containing DXS228. The CA repeats, and other markers from proximal Xp, were mapped genetically in CEPH families and the likely order of markers was established as Xpter-(DXS7, MAO-A, DXS228)-(PFC, DXS426)-(TIMP, OATL1)-DXS255-Xcen. This places PFC in the region Xp11.3-Xp11.23, thus refining previous in situ hybridization data. Two yeast artificial chromosomes (YACs) (440 and 390 kb) contain both PFC and DXS426, and one of them (440 kb) also contains TIMP. This confirms the genetic order TIMP-(PFC, DXS426). PFC and TIMP are located on the same 100-kb SalI/PvuI fragment of the 440-kb YAC. Given the genetic orientation of TIMP and (PFC, DXS426), this YAC can now serve as a starting point for directional walking toward disease genes located in Xp11.3-Xp11.2 such as retinitis pigmentosa (RP2) and Wiskott-Aldrich syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783405     DOI: 10.1016/0888-7543(91)90024-9

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

Review 1.  Properdin deficiency and meningococcal disease--identifying those most at risk.

Authors:  S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Localisation of the gene for Norrie disease to between DXS7 and DXS426 on Xp.

Authors:  S Lindsay; D L Thiselton; J B Bateman; J T Ngo; R S Sparkes; M Coleman; K E Davies; S S Bhattacharya
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

3.  X-linked recessive panhypopituitarism associated with a regional duplication in Xq25-q26.

Authors:  M Lagerström-Fermér; M Sundvall; E Johnsen; G L Warne; S M Forrest; J D Zajac; A Rickards; D Ravine; U Landegren; U Pettersson
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Male neonatal death and progressive weakness and immune deficiency in females: an unknown X linked condition.

Authors:  G Woods; G Black; G Norbury
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

5.  Carrier detection in families with properdin deficiency by microsatellite haplotyping.

Authors:  K Kölble; A J Cant; A C Fay; K Whaley; M Schlesinger; K B Reid
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  Linkage of Wiskott-Aldrich syndrome with three marker loci, DXS426, SYP and TFE3, which map to the Xp11.3-p11.22 region.

Authors:  S M Cremin; W L Greer; R Bodok-Nutzati; M Schwartz; M Peacocke; K A Siminovitch
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

7.  Polymorphisms of the glucocorticoid receptor gene in laboratory and wild rats: steroid binding properties of trinucleotide CAG repeat length variants.

Authors:  R P Heeley; E Gill; B van Zutphen; C J Kenyon; R G Sutcliffe
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

8.  Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.

Authors:  G N Fredrikson; B Gullstrand; J Westberg; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

9.  X chromosome linkage studies in familial Rett syndrome.

Authors:  A R Curtis; S Headland; S Lindsay; N S Thomas; E Boye; S Kamakari; P Roustan; M Anvret; J Wahlstrom; G McCarthy
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

Review 10.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.